BIOMAT Database Logo BIOMAT Database Logo

Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. 1994

M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
University of Minnesota Medical Center, Minneapolis.

OBJECTIVE In an effort to evaluate the usefulness of bone marrow transplantation, the Childrens Cancer Group (CCG) initiated a multiinstitutional study comparing bone marrow transplantation versus chemotherapy after successful induction of remission for previously untreated children and young adults with acute myeloid leukemia. METHODS From 1979 to 1983, 508 patients were entered onto this study and 490 were treated. After induction, patients with an HLA mixed leukocyte culture (MLC)-compatible sibling underwent bone marrow transplantation. Patients not eligible for bone marrow transplantation were eligible for randomization to two chemotherapy maintenance regimens. All patients undergoing bone marrow transplantation were conditioned with cyclophosphamide and total-body irradiation (TBI). Methotrexate was used to prevent or modify graft-versus-host disease (GVHD). RESULTS Three hundred eighty-one patients achieved bone marrow remission (78%). Eighty-nine patients had an HLA/MLC-compatible sibling donor and were eligible for bone marrow transplantation, and 252 had no match. Comparison of survival estimates for patients eligible for transplantation versus not eligible at 3 years (52% v 41%), 5 years (50% v 36%), and 8 years (47% v 34%) showed a significant difference in favor of bone marrow transplantation (P < .05). Disease-free survival (DFS) demonstrated similar results. Application of a cure model to the results showed a better outcome for those eligible for transplantation (P = .04). Patients randomized between the two chemotherapy regimens did not show any significant difference between those treated with a continuous maintenance versus a cyclic regimen (P = .16). CONCLUSIONS Children and young adults who successfully achieved a remission with multiple-agent chemotherapy who had an HLA/MLC-compatible donor and were thus eligible for an allogeneic bone marrow transplant had better survival than those not eligible for transplantation.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
August 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Cytosine arabinoside and mitoxantrone induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia.
October 1994, Leukemia,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group.
January 1979, Medical and pediatric oncology,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Post-remission treatment in acute myeloid leukemia: chemotherapy or autologous or allogeneic bone marrow transplantation.
January 1990, Haematologica,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
April 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison.
November 1984, Annals of internal medicine,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Allogeneic bone marrow transplantation versus chemotherapy in first-remission acute myeloid leukemia.
July 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
January 1996, Leukemia,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group.
January 1983, Medical and pediatric oncology,
M E Nesbit, and J D Buckley, and S A Feig, and J R Anderson, and B Lampkin, and I D Bernstein, and T H Kim, and S Piomelli, and J H Kersey, and P F Coccia
[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation].
March 1991, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!